![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach:
Dokumententyp
| Veröffentlichungsdatum
Springe zu: Zeitschriftenartikel
Anzahl der Publikationen: 3
Zeitschriftenartikel
Kappos, Ludwig; Fox, Robert J.; Burcklen, Michel; Freedman, Mark S.; Havrdova, Eva K.; Hennessy, Brian; Hohlfeld, Reinhard; Lublin, Fred; Montalban, Xavier; Pozzilli, Carlo; Scherz, Tatiana; D'Ambrosio, Daniele; Linscheid, Philippe; Vaclavkova, Andrea; Pirozek-Lawniczek, Magdalena; Kracker, Hilke und Sprenger, Till
(2021):
Ponesimod Compared With Teriflunomide in Patients With Relapsing Multiple Sclerosis in the Active-Comparator Phase 3 OPTIMUM Study A Randomized Clinical Trial.
In: Jama Neurology, Bd. 78, Nr. 5: S. 558-567
[PDF, 428kB]
Cortese, Marianna; Munger, Kassandra L.; Martinez-Lapiscina, Elena H.; Barro, Christian; Edan, Gilles; Freedman, Mark S.; Hartung, Hans-Peter; Montalban, Xavier; Foley, Frederick W.; Penner, Iris Katharina; Hemmer, Bernhard; Fox, Edward J.; Schippling, Sven; Wicklein, Eva-Maria; Kappos, Ludwig; Kuhle, Jens und Ascherio, Alberto
(2020):
Vitamin D, smoking, EBV, and long-term cognitive performance in MS 11-year follow-up of BENEFIT.
In: Neurology, Bd. 94, Nr. 18, E1950-E1960
D'Ambrosio, Daniele; Freedman, Mark S. und Prinz, Joerg
(2016):
Ponesimod, a selective S1P1 receptor modulator: a potential treatment for multiple sclerosis and other immune-mediated diseases.
In: Therapeutic Advances in Chronic Disease, Bd. 7, Nr. 1: S. 18-33
[PDF, 126kB]